DNDi works with partners in disease-endemic countries to strengthen existing clinical research capacity. Research platforms and networks facilitate knowledge sharing and training, as well as infrastructural upgrading of research centres for clinical trials. The expertise of their members help to ensure that target product profiles for treatments address patients’ real needs.

Regional platforms

DNDi helped in setting up and works with 4 regional disease-specific platforms and networks in Africa and Latin America:

 Their mission is to:

  • Define patients’ needs, taking into consideration the local settings
  • Bring together key regional actors in health field, namely representatives of ministries of health, national control programmes, regulatory authorities, academia, civil society groups, and pharmaceutical companies, as well as clinicians and health professionals
  • Utilize, capitalize upon, and reinforce clinical capacities in endemic regions, and address infrastructural requirements where necessary
  • Provide on-site training in clinical research in sometimes very remote settings
  • Contribute to regulatory processes, uptake, and sustainable access of new treatments.

 

 

Technology transfer

For DNDi, the transfer of technology consists of transferring the industrial development know-how to partners in endemic regions in order to:

  • Ensure a wide-spread distribution of new treatments
  • Maintain competitive prices
  • Reinforce the technological and scientific capacities of endemic countries

To date, DNDi has actively participated in the process of technology transfer between Farmanguinhos and Cipla (ASMQ), and the transfer of technology to Zenufa for ASAQ